Markers of tumor angiogenesis: clinical applications in prognosis and anti-angiogenic therapy

[1]  Wei-Jei Lee,et al.  Breast cancer angiogenesis: A quantitative morphologic and doppler imaging study , 1995, Annals of Surgical Oncology.

[2]  A. Sapino,et al.  Morphometric evaluation of microvessels surrounding hyperplastic and neoplastic mammary lesions , 1988, Breast Cancer Research and Treatment.

[3]  H. Höfler,et al.  Urokinase (uPA) and its inhibitor PAI-1 are strong and independent prognostic factors in node-negative breast cancer , 2005, Breast Cancer Research and Treatment.

[4]  P. Lipponen,et al.  Tumour vascularity and basement membrane structure in breast cancer as related to tumour histology and prognosis , 2005, Journal of Cancer Research and Clinical Oncology.

[5]  Brygida Berse,et al.  Vascular permeability factor (VPF, VEGF) in tumor biology , 1993, Cancer and Metastasis Reviews.

[6]  P. Wesseling,et al.  Cellular components of microvascular proliferation in human glial and metastatic brain neoplasms , 1993, Acta Neuropathologica.

[7]  Rakesh K. Jain,et al.  Vascular and interstitial barriers to delivery of therapeutic agents in tumors , 1990, Cancer and Metastasis Reviews.

[8]  P. Salama.  [Thrombosis and cancer]. , 2004, Anales del sistema sanitario de Navarra.

[9]  S. Fox,et al.  Tumor angiogenesis in node-negative breast carcinomas — relationship with epidermal growth factor receptor, estrogen receptor, and survival , 2004, Breast Cancer Research and Treatment.

[10]  N. Weidner,et al.  Determination of epidermal growth factor receptor provides additional prognostic information to measuring tumor angiogenesis in breast carcinoma patients , 2004, Breast Cancer Research and Treatment.

[11]  M. Toi,et al.  Tumor angiogenesis in breast cancer: Its importance as a prognostic indicator and the association with vascular endothelial growth factor expression , 2004, Breast Cancer Research and Treatment.

[12]  J. Jing,et al.  [Tumor angiogenesis in node-negative breast carcinoma]. , 2002, Ai zheng = Aizheng = Chinese journal of cancer.

[13]  J. Sloane,et al.  Angiogenesis in ductal carcinoma in situ (DCIS) of the breast , 2001 .

[14]  S. Fox,et al.  Up‐regulation of thymidine phosphorylase expression is associated with a discrete pattern of angiogenesis in ductal carcinomas in situ of the breast , 1997, The Journal of pathology.

[15]  A. Harris,et al.  PROGNOSTIC VALUE OF ANGIOGENESIS IN OPERABLE NON‐SMALL CELL LUNG CANCER , 1996, The Journal of pathology.

[16]  S. Fox,et al.  The angiogenic factor platelet-derived endothelial cell growth factor/thymidine phosphorylase is up-regulated in breast cancer epithelium and endothelium. , 1996, British Journal of Cancer.

[17]  S. Fox,et al.  Re: Tumor angiogenesis as a prognostic assay for invasive ductal breast carcinoma. , 1995, Journal of the National Cancer Institute.

[18]  A. Harris,et al.  The increased expression of adhesion molecules ICAM‐3, E‐ and P‐selectins on breast cancer endothelium , 1995, The Journal of pathology.

[19]  A. Harris,et al.  Quantitation and prognostic value of breast cancer angiogenesis: Comparison of microvessel density, Chalkley count, and computer image analysis , 1995, The Journal of pathology.

[20]  F. Sarkar,et al.  Antiintegrin alpha v beta 3 blocks human breast cancer growth and angiogenesis in human skin. , 1995, The Journal of clinical investigation.

[21]  L. Ellis,et al.  Expression of vascular endothelial growth factor and its receptor, KDR, correlates with vascularity, metastasis, and proliferation of human colon cancer. , 1995, Cancer research.

[22]  A. Harris,et al.  Urinary basic fibroblast growth factor in patients with bladder cancer and benign prostatic hypertrophy. , 1995, British journal of urology.

[23]  Anthony J. Guidi,et al.  Vascular permeability factor (vascular endothelial growth factor) expression and angiogenesis in cervical neoplasia. , 1995, Journal of the National Cancer Institute.

[24]  A. Koch,et al.  Angiogenesis mediated by soluble forms of E-selectin and vascular cell adhesion molecule-1 , 1995, Nature.

[25]  R. Iozzo.  Tumor stroma as a regulator of neoplastic behavior. Agonistic and antagonistic elements embedded in the same connective tissue. , 1995, Laboratory investigation; a journal of technical methods and pathology.

[26]  S. Burchill,et al.  The molecular detection of circulating tumour cells. , 1995, British Journal of Cancer.

[27]  S. Steinberg,et al.  Tumor angiogenesis in advanced stage ovarian carcinoma. , 1995, The American journal of pathology.

[28]  P. Carroll,et al.  Tumor angiogenesis correlates with lymph node metastases in invasive bladder cancer. , 1995, The Journal of urology.

[29]  S. Rakar,et al.  Colour and pulsed Doppler US and tumour marker CA 125 in differentiation between benign and malignant ovarian masses. , 1995, Anticancer research.

[30]  M J Bissell,et al.  Involvement of extracellular matrix constituents in breast cancer. , 1995, Seminars in cancer biology.

[31]  Y. Chung,et al.  Microvessel quantitation in invasive breast cancer by staining for factor VIII-related antigen. , 1995, British Journal of Cancer.

[32]  H. Ishitsuka,et al.  Expression of platelet‐derived endothelial cell growth factor/thymidine phosphorylase in human breast cancer , 1995, International journal of cancer.

[33]  T. Liu,et al.  Expression of basic fibroblast growth factor in squamous cell carcinoma of the head and neck is associated with degree of histologic differentiation , 1995, International journal of cancer.

[34]  Rutgers Jl,et al.  Angiogenesis in uterine cervical squamous cell carcinoma , 1995 .

[35]  L Piana,et al.  CD31 quantitative immunocytochemical assays in breast carcinomas. Correlation with current prognostic factors. , 1995, American journal of clinical pathology.

[36]  J. Klijanienko,et al.  Tumor vascularization, mitotic index, histopathologic grade, and DNA ploidy in the assessment of 114 head and neck squamous cell carcinomas , 1995, Cancer.

[37]  A. Harris,et al.  Clinical importance of the determination of tumor angiogenesis in breast carcinoma: much more than a new prognostic tool. , 1995, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[38]  D. Schadendorf,et al.  Association with clinical outcome of expression of VLA-4 in primary cutaneous malignant melanoma as well as P-selectin and E-selectin on intratumoral vessels. , 1995, Journal of the National Cancer Institute.

[39]  D L Wiggins,et al.  Tumor angiogenesis as a prognostic factor in cervical carcinoma. , 1995, Gynecologic oncology.

[40]  Mariann F. Brown,et al.  Microvascularity in benign prostatic hyperplasia , 1995, The Prostate.

[41]  S. Fox,et al.  Thymidine phosphorylase is angiogenic and promotes tumor growth. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[42]  Y. Chung,et al.  Tumor angiogenesis as a predictor of recurrence in gastric carcinoma. , 1995, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[43]  A. Harris,et al.  Different angiogenic pathways characterize superficial and invasive bladder cancer. , 1995, Cancer research.

[44]  S. Fox,et al.  Breast cancer angiogenesis and tamoxifen resistance , 1995 .

[45]  Claudio Eccher,et al.  Microvessel density quantification in breast carcinomas. Assessment by light microscopy vs. a computer-aided image analysis system , 1995 .

[46]  Anthony J. Guidi,et al.  Expression of vascular permeability factor (vascular endothelial growth factor) and its receptors in breast cancer. , 1995, Human pathology.

[47]  K. Chew,et al.  Tumor angiogenesis as a prognostic assay for invasive ductal breast carcinoma. , 1995, Journal of the National Cancer Institute.

[48]  F. Sarkar,et al.  Biologic and clinical significance of basic fibroblast growth factor immunostaining in breast carcinoma. , 1995, Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc.

[49]  Y. Tomita,et al.  Angiogenesis in malignant fibrous histiocytoma. , 1995, Oncology.

[50]  D. Cheresh,et al.  Integrin α v β 3 antagonists promote tumor regression by inducing apoptosis of angiogenic blood vessels , 1994, Cell.

[51]  S. Fox,et al.  Quantification of angiogenesis as an independent predictor of prognosis in invasive bladder carcinomas. , 1994, British journal of urology.

[52]  P. Troncoso,et al.  Significance of tumor angiogenesis in clinically localized prostate carcinoma treated with external beam radiotherapy. , 1994, Urology.

[53]  R. Paola,et al.  Correlation Between Contrast Enhancement in Dynamic Magnetic Resonance Imaging of the Breast and Tumor Angiogenesis , 1994, Investigative radiology.

[54]  S. Wakui,et al.  Tumour angiogenesis in latent prostatic carcinoma. , 1994, British Journal of Cancer.

[55]  C. Cohen,et al.  Tumor angiogenesis as a prognostic factor in oral cavity tumors. , 1994, American journal of surgery.

[56]  D. Elder,et al.  Tumour vascularity is not a prognostic factor for cutaneous melanoma , 1994, The Lancet.

[57]  Lars Holmgren,et al.  Angiostatin: A novel angiogenesis inhibitor that mediates the suppression of metastases by a lewis lung carcinoma , 1994, Cell.

[58]  M. Toi,et al.  Association of Vascular Endothelial Growth Factor Expression with Tumor Angiogenesis and with Early Relapse in Primary Breast Cancer , 1994, Japanese journal of cancer research : Gann.

[59]  F. Luscinskas,et al.  Integrins as dynamic regulators of vascular function , 1994, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[60]  T. Saclarides,et al.  Tumor angiogenesis and rectal carcinoma , 1994, Diseases of the colon and rectum.

[61]  C. Jackson,et al.  VLA‐2 mediates the interaction of collagen with endothelium during in vitro vascular tube formation. , 1994, Cell Biology International.

[62]  M. Wick,et al.  Midkine and pleiotrophin expression in normal and malignant breast tissue , 1994, Cancer.

[63]  P. Bongrand,et al.  A novel role for E- and P-selectins: shape control of endothelial cell monolayers. , 1994, Journal of cell science.

[64]  T. Bourne,et al.  Association of ovarian malignancy with expression of platelet-derived endothelial cell growth factor. , 1994, Journal of the National Cancer Institute.

[65]  H. Verspaget,et al.  Urokinase receptor and colorectal cancer survival , 1994, The Lancet.

[66]  P. Black,et al.  Microvessel count and cerebrospinal fluid basic fibroblast growth factor in children with brain tumours , 1994, The Lancet.

[67]  A. Blann,et al.  Circulating Endothelial Cell/Leukocyte Adhesion Molecules in Atherosclerosis , 1994, Thrombosis and Haemostasis.

[68]  G. Fontanini,et al.  Angiogenesis: an indicator of metastasis in non-small cell lung cancer invading the thoracic inlet. , 1994, The Annals of thoracic surgery.

[69]  M. Granick,et al.  The Relationship of Angiogenesis to Biological Activity in Human Squamous Cell Carcinomas of the Head and Neck , 1994, Annals of plastic surgery.

[70]  G. Sledge,et al.  Neovascularization in clinical stage A testicular germ cell tumor: prediction of metastatic disease. , 1994, Cancer research.

[71]  D. Cheresh,et al.  Requirement of vascular integrin alpha v beta 3 for angiogenesis. , 1994, Science.

[72]  J. Bahi,et al.  Angiogenesis and risk of breast cancer in women with fibrocystic disease. , 1994, Journal of the National Cancer Institute.

[73]  Anthony J. Guidi,et al.  Microvessel density and distribution in ductal carcinoma in situ of the breast. , 1994, Journal of the National Cancer Institute.

[74]  R. Poorman,et al.  Interstitial collagenase is required for angiogenesis in vitro. , 1994, Developmental biology.

[75]  S. Leinster,et al.  Comparative expression of fibroblast growth factor mRNAs in benign and malignant breast disease. , 1994, British Journal of Cancer.

[76]  S. Kondo,et al.  Vascular endothelial growth factor/vascular permeability factor is detectable in the sera of tumor-bearing mice and cancer patients. , 1994, Biochimica et biophysica acta.

[77]  J. Richie,et al.  Elevated levels of an angiogenic peptide, basic fibroblast growth factor, in the urine of patients with a wide spectrum of cancers. , 1994, Journal of the National Cancer Institute.

[78]  P. Lipponen,et al.  Tumor vascularity and basement membrane structure as prognostic factors in T1-2MO prostatic adenocarcinoma. , 1994, Anticancer research.

[79]  N. Weidner,et al.  Tumor microvessel density, p53 expression, tumor size, and peritumoral lymphatic vessel invasion are relevant prognostic markers in node-negative breast carcinoma. , 1994, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[80]  Chien-Nan Lee,et al.  Incremental angiogenesis assessed by color doppler ultrasound in the tumorigenesis of ovarian neoplasms , 1994, Cancer.

[81]  M. Brawer,et al.  Predictors of pathologic stage in prostatic carcinoma. The role of neovascularity , 1994, Cancer.

[82]  B. Seed,et al.  4A11, a monoclonal antibody recognizing a novel antigen expressed on aberrant vascular endothelium. Upregulation in an in vivo model of contact dermatitis. , 1994, The American journal of pathology.

[83]  C. Cockerell,et al.  Comparative Analysis of Neovascularization in Primary Cutaneous Melanoma and Spitz Nevus , 1994, The American Journal of dermatopathology.

[84]  K. Smith-McCune,et al.  Demonstration and characterization of the angiogenic properties of cervical dysplasia. , 1994, Cancer research.

[85]  M. Piontek,et al.  Vascularization of carcinomas of the esophagus and its correlation with tumor proliferation. , 1994, Cancer research.

[86]  D. Cheresh,et al.  Integrin alpha v beta 3 antagonists promote tumor regression by inducing apoptosis of angiogenic blood vessels. , 1994, Cell.

[87]  N. Weidner,et al.  Tumor angiogenesis, the p53 antigen, and cervical metastasis in squamous carcinoma of the tongue. , 1994, Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery.

[88]  F. Burrows,et al.  Vascular targeting--a new approach to the therapy of solid tumors. , 1994, Pharmacology & therapeutics.

[89]  U. Schumacher,et al.  Are tumours innervated? Immunohistological investigations using antibodies against the neuronal marker protein gene product 9.5 (PGP 9.5) in benign, malignant and experimental tumours. , 1994, Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine.

[90]  R. Kendall,et al.  Inhibition of vascular endothelial cell growth factor activity by an endogenously encoded soluble receptor. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[91]  N. Weidner,et al.  Intratumoral microvessel density and L53 protein: Correlation with metastasis in head‐and‐neck squamous‐cell carcinoma , 1993, International journal of cancer.

[92]  N. S. Larsen.  Angiogenesis research yields new approaches to cancer treatment and prognosis. , 1993, Journal of the National Cancer Institute.

[93]  K. Kashima,et al.  Identification of basic fibroblast growth factor in papillary carcinoma of the thyroid , 1993, Acta pathologica japonica.

[94]  M. Toi,et al.  Tumor angiogenesis is an independent prognostic indicator in primary breast carcinoma , 1993, International journal of cancer.

[95]  J. Bischoff,et al.  A role for sialyl Lewis-X/A glycoconjugates in capillary morphogenesis , 1993, Nature.

[96]  R Bicknell,et al.  Relationship of endothelial cell proliferation to tumor vascularity in human breast cancer. , 1993, Cancer research.

[97]  S. Fox,et al.  High levels of uPA and PA1 are associated with highly angiogenic breast carcinomas , 1993 .

[98]  R. Folberg,et al.  The prognostic value of tumor blood vessel morphology in primary uveal melanoma. , 1993, Ophthalmology.

[99]  K. Lapis,et al.  Morphological aspects of angiogenesis in experimental liver metastases. , 1993, The American journal of pathology.

[100]  S. Ferrone,et al.  Clinical relevance of ICAM-1 expression in primary lesions and serum of patients with malignant melanoma. , 1993, Cancer research.

[101]  W Blumenfeld,et al.  Tumor angiogenesis correlates with metastasis in invasive prostate carcinoma. , 1993, The American journal of pathology.

[102]  P. Selby,et al.  Circulating intercellular adhesion molecule-1 (ICAM-1), E-selectin and vascular cell adhesion molecule-1 (VCAM-1) in human malignancies. , 1993, British Journal of Cancer.

[103]  M Scarpelli,et al.  Prostatic Intra-epithelial Neoplasia: Qualitative and Quantitative Analyses of the Blood Capillary Architecture on Thin Tissue Sections , 1993 .

[104]  N. Brünner,et al.  High levels of urokinase-type plasminogen activator and its inhibitor PAI-1 in cytosolic extracts of breast carcinomas are associated with poor prognosis. , 1993, Cancer research.

[105]  S. Kumar,et al.  A monoclonal antibody detects heterogeneity in vascular endothelium of tumours and normal tissues , 1993, International journal of cancer.

[106]  J. Gamble,et al.  Regulation of in vitro capillary tube formation by anti-integrin antibodies , 1993, The Journal of cell biology.

[107]  M. Schwartz,et al.  Integrin beta 1- and beta 3-mediated endothelial cell migration is triggered through distinct signaling mechanisms , 1993, The Journal of cell biology.

[108]  S. Schultz-Hector,et al.  β-Fibroblast Growth Factor Expression in Human and Murine Squamous Cell Carcinomas and Its Relationship to Regional Endothelial Cell Proliferation , 1993 .

[109]  A. Poggi,et al.  Lymphocyte-endothelial cell adhesion molecules at the primary tumor site in human lung and renal cell carcinomas. , 1993, Journal of the National Cancer Institute.

[110]  J. Richie,et al.  Elevated levels of the angiogenic peptide basic fibroblast growth factor in urine of bladder cancer patients. , 1993, Journal of the National Cancer Institute.

[111]  A. Laurenza,et al.  Identification of a role of the vitronectin receptor and protein kinase C in the induction of endothelial cell vascular formation , 1993, Journal of cellular biochemistry.

[112]  M. Brawer,et al.  Comparison of microscopic vascularity in benign and malignant prostate tissue. , 1993, Human pathology.

[113]  E Protopapa,et al.  Vascular density and the response of breast carcinomas to mastectomy and adjuvant chemotherapy. , 1993, European journal of cancer.

[114]  A. Howell,et al.  Assessment of tumour vascularity as a prognostic factor in lymph node negative invasive breast cancer. , 1993, European journal of cancer.

[115]  R. Zarnegar,et al.  Expression of HGF-SF in normal and malignant human tissues. , 1993, EXS.

[116]  D. Visscher,et al.  Prognostic significance of image morphometric microvessel enumeration in breast carcinoma. , 1993, Analytical and quantitative cytology and histology.

[117]  F Pozza,et al.  Tumor angiogenesis: a new significant and independent prognostic indicator in early-stage breast carcinoma. , 1992, Journal of the National Cancer Institute.

[118]  L. Orci,et al.  Potent synergism between vascular endothelial growth factor and basic fibroblast growth factor in the induction of angiogenesis in vitro. , 1992, Biochemical and biophysical research communications.

[119]  J. Azizkhan,et al.  In vitro model of angiogenesis using a human endothelium‐derived permanent cell line: Contributions of induced gene expression, G‐proteins, and integrins , 1992, Journal of cellular physiology.

[120]  B. Teicher,et al.  Antiangiogenic agents potentiate cytotoxic cancer therapies against primary and metastatic disease. , 1992, Cancer research.

[121]  J. Healey,et al.  Identification of endosialin, a cell surface glycoprotein of vascular endothelial cells in human cancer. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[122]  A. Harris,et al.  Angiogenesis, assessed by platelet/endothelial cell adhesion molecule antibodies, as indicator of node metastases and survival in breast cancer , 1992, The Lancet.

[123]  H. Sasaki,et al.  Tumour angiogenesis in prostatic carcinoma with and without bone marrow metastasis: A morphometric study , 1992, The Journal of pathology.

[124]  J. Foekens,et al.  Prognostic value of urokinase-type plasminogen activator in 671 primary breast cancer patients. , 1992, Cancer research.

[125]  C. Benjamin,et al.  Leukocyte accumulation promoting fibrin deposition is mediated in vivo by P-selectin on adherent platelets , 1992, Nature.

[126]  M C Mihm,et al.  Angiogenesis and tumor progression of melanoma. Quantification of vascularity in melanocytic nevi and cutaneous malignant melanoma. , 1992, Laboratory investigation; a journal of technical methods and pathology.

[127]  F. Spyratos,et al.  Multiparametric prognostic evaluation of biological factors in primary breast cancer. , 1992, Journal of the National Cancer Institute.

[128]  C. Angeletti,et al.  Relation of neovascularisation to metastasis of non-small-cell lung cancer , 1992, The Lancet.

[129]  A. Lee,et al.  Microvessel quantitation and prognosis in invasive breast carcinoma. , 1992, Human pathology.

[130]  J. Monson,et al.  Is the relationship between angiogenesis and metastasis in breast cancer real? , 1992, Surgical oncology.

[131]  S. Wong,et al.  Thrombospondin and other possible related matrix proteins in malignant and benign breast disease. An immunohistochemical study. , 1992, The American journal of pathology.

[132]  E. Stopa,et al.  Localization of basic fibroblast growth factor and vascular endothelial growth factor in human glial neoplasms. , 1992, Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc.

[133]  M. Mihm,et al.  Angiogenesis and regressing cutaneous malignant melanoma , 1992, The Lancet.

[134]  T. Urano,et al.  Plasminogen activator system in human breast cancer , 1992, International journal of cancer.

[135]  R Bicknell,et al.  Heterogeneity of vascular endothelial cells with relevance to diagnosis of vascular tumours. , 1992, Journal of clinical pathology.

[136]  F. Jänicke,et al.  Tumor-associated urokinase-type plasminogen activator: biological and clinical significance. , 1992, Biological chemistry Hoppe-Seyler.

[137]  L. Orci,et al.  Vascular endothelial growth factor (VEGF) induces plasminogen activators and plasminogen activator inhibitor-1 in microvascular endothelial cells. , 1991, Biochemical and biophysical research communications.

[138]  T. Sugimura,et al.  Increased serum levels of basic fibroblast growth factor in patients with renal cell carcinoma. , 1991, Biochemical and biophysical research communications.

[139]  R. Coombes,et al.  Localization of basic fibroblast growth factor and transforming growth factor beta 1 in the human mammary gland. , 1991, Cancer research.

[140]  G. Westbury,et al.  The vascularity of cutaneous melanoma: a quantitative histological study of lesions 0.85-1.25 mm in thickness. , 1991, British Journal of Cancer.

[141]  A. Harris,et al.  Novel growth regulatory factors and tumour angiogenesis. , 1991, European journal of cancer.

[142]  J. Folkman,et al.  Tumor angiogenesis and metastasis--correlation in invasive breast carcinoma. , 1991, The New England journal of medicine.

[143]  S. McCarthy,et al.  Heterogeneity of the endothelial cell and its role in organ preference of tumour metastasis. , 1991, Trends in pharmacological sciences.

[144]  R. Montesano,et al.  Proteolytic balance and capillary morphogenesis. , 1990, Cell differentiation and development : the official journal of the International Society of Developmental Biologists.

[145]  M. Duffy,et al.  Urokinase-plasminogen activator, a new and independent prognostic marker in breast cancer. , 1990, Cancer research.

[146]  D. Mason,et al.  JC70: a new monoclonal antibody that detects vascular endothelium associated antigen on routinely processed tissue sections. , 1990, Journal of clinical pathology.

[147]  L. Orci,et al.  Transforming growth factor-beta 1 modulates basic fibroblast growth factor-induced proteolytic and angiogenic properties of endothelial cells in vitro , 1990, The Journal of cell biology.

[148]  B. Zetter,et al.  Tumor interactions with the vasculature: angiogenesis and tumor metastasis. , 1990, Biochimica et biophysica acta.

[149]  P. Okunieff,et al.  Blood flow, oxygen and nutrient supply, and metabolic microenvironment of human tumors: a review. , 1989, Cancer research.

[150]  R. Hofmann-Wellenhof,et al.  Vascular architecture of melanocytic skin tumors. A quantitative immunohistochemical study using automated image analysis. , 1989, Pathology, research and practice.

[151]  H D Suit,et al.  Comparative morphometric study of tumor vasculature in human squamous cell carcinomas and their xenotransplants in athymic nude mice. , 1989, Cancer research.

[152]  J. Spławiński,et al.  Angiogenic activity and neovascularization in adenocarcinoma of endometrium , 1989, International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics.

[153]  N Paweletz,et al.  Tumor-related angiogenesis. , 1989, Critical reviews in oncology/hematology.

[154]  A. Srivastava,et al.  The prognostic significance of tumor vascularity in intermediate-thickness (0.76-4.0 mm thick) skin melanoma. A quantitative histologic study. , 1988, The American journal of pathology.

[155]  S. Brem,et al.  Neovascularization and tumor growth in the rabbit brain. A model for experimental studies of angiogenesis and the blood-brain barrier. , 1988, The American journal of pathology.

[156]  W. Risau,et al.  Tumor necrosis factor type alpha, a potent inhibitor of endothelial cell growth in vitro, is angiogenic in vivo. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[157]  D. Gospodarowicz,et al.  Tumor necrosis factor inhibits the proliferation of cultured capillary endothelial cells. , 1987, Biochemical and biophysical research communications.

[158]  S. Goerdt,et al.  A monoclonal antibody reacting with endothelial cells of budding vessels in tumors and inflammatory tissues, and non‐reactive with normal adult tissues , 1986, International journal of cancer.

[159]  C. Streffer,et al.  Measurement of the grade of vascularisation in histological tumour tissue sections. , 1985, British Journal of Cancer.

[160]  D. Ruiter,et al.  Monoclonal antibody PAL-E specific for endothelium. , 1985, Laboratory investigation; a journal of technical methods and pathology.

[161]  K. Danø,et al.  Human endothelial cells contain one type of plasminogen activator , 1984, FEBS letters.

[162]  K. Danø,et al.  Distribution of urokinase-type plasminogen activator immunoreactivity in the mouse , 1984, The Journal of cell biology.

[163]  H M Jensen,et al.  Angiogenesis induced by "normal" human breast tissue: a probable marker for precancer. , 1982, Science.

[164]  S. Brem,et al.  Angiogenesis as a marker of preneoplastic lesions of the human breast , 1978, Cancer.

[165]  J. Folkman,et al.  Tumor angiogenesis: a quantitative method for histologic grading. , 1972, Journal of the National Cancer Institute.

[166]  J. Folkman.  Tumor angiogenesis: therapeutic implications. , 1971, The New England journal of medicine.

[167]  H. Schaumburg,et al.  N-hexane neuropathy. A syndrome occurring as a result of industrial exposure. , 1971, The New England journal of medicine.

[168]  L. Forssman,et al.  Myometrial blood flow studies in carcinoma of the corpus uteri. A preliminary report on the clearance method using xenon 133. , 1969, Acta radiologica: therapy, physics, biology.

[169]  H. W. Chalkley.  Method for the Quantitative Morphologic Analysis of Tissues , 1943 .